An open-label efficacy pilot study with pimecrolimus cream 1% in adults with facial seborrhoeic dermatitis infected with HIV.
de Moraes, A P
An open-label efficacy pilot study with pimecrolimus cream 1% in adults with facial seborrhoeic dermatitis infected with HIV. [electronic resource] - Journal of the European Academy of Dermatology and Venereology : JEADV May 2007 - 596-601 p. digital
Publication Type: Journal Article
0926-9959
10.1111/j.1468-3083.2006.01923.x doi
Administration, Topical
Adult
Dermatitis, Seborrheic--complications
Dermatologic Agents--administration & dosage
Facial Dermatoses--complications
Female
HIV Infections--complications
Humans
Male
Middle Aged
Ointments
Pilot Projects
Recurrence
Tacrolimus--administration & dosage
Treatment Outcome
An open-label efficacy pilot study with pimecrolimus cream 1% in adults with facial seborrhoeic dermatitis infected with HIV. [electronic resource] - Journal of the European Academy of Dermatology and Venereology : JEADV May 2007 - 596-601 p. digital
Publication Type: Journal Article
0926-9959
10.1111/j.1468-3083.2006.01923.x doi
Administration, Topical
Adult
Dermatitis, Seborrheic--complications
Dermatologic Agents--administration & dosage
Facial Dermatoses--complications
Female
HIV Infections--complications
Humans
Male
Middle Aged
Ointments
Pilot Projects
Recurrence
Tacrolimus--administration & dosage
Treatment Outcome